» Articles » PMID: 24429391

Krüppel-like Factors in Cancer Progression: Three Fingers on the Steering Wheel

Overview
Journal Oncotarget
Specialty Oncology
Date 2014 Jan 17
PMID 24429391
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Krüppel-like factors (KLFs) comprise a highly conserved family of zinc finger transcription factors, that are involved in a plethora of cellular processes, ranging from proliferation and apoptosis to differentiation, migration and pluripotency. During the last few years, evidence on their role and deregulation in different human cancers has been emerging. This review will discuss current knowledge on Krüppel-like transcription in the epithelial-mesenchymal transition (EMT), invasion and metastasis, with a focus on epithelial cancer biology and the extensive interface with pluripotency. Furthermore, as KLFs are able to mediate different outcomes, important influences of the cellular and microenvironmental context will be highlighted. Finally, we attempt to integrate diverse findings on KLF functions in EMT and stem cell biology to fit in the current model of cellular plasticity as a tool for successful metastatic dissemination.

Citing Articles

Exploring the roles and therapeutic implications of melatonin-mediated KLF6 in the development of intracranial aneurysm.

Liu Y, Su Y, Chen L, Li A, Ma Z Ann Med. 2024; 56(1):2397568.

PMID: 39215680 PMC: 11370671. DOI: 10.1080/07853890.2024.2397568.


Kruppel-like factor 13 acts as a tumor suppressor in thyroid carcinoma by downregulating IFIT1.

Liu Y, Song Y, He Y, Kong Z, Li H, Zhu Y Biol Direct. 2023; 18(1):65.

PMID: 37817224 PMC: 10565980. DOI: 10.1186/s13062-023-00422-5.


Krüppel-like Factors 4 and 5 in Colorectal Tumorigenesis.

Lee E, Cheung J, Bialkowska A Cancers (Basel). 2023; 15(9).

PMID: 37173904 PMC: 10177156. DOI: 10.3390/cancers15092430.


KLF9 and KLF13 transcription factors boost myelin gene expression in oligodendrocytes as partners of SOX10 and MYRF.

Bernhardt C, Sock E, Frob F, Hillgartner S, Nemer M, Wegner M Nucleic Acids Res. 2022; 50(20):11509-11528.

PMID: 36318265 PMC: 9723594. DOI: 10.1093/nar/gkac953.


Mutated KLF4(K409Q) in meningioma binds STRs and activates gene expression.

Tsytsykova A, Wiley G, Li C, Pelikan R, Garman L, Acquah F iScience. 2022; 25(8):104839.

PMID: 35996584 PMC: 9391581. DOI: 10.1016/j.isci.2022.104839.


References
1.
Rowland B, Bernards R, Peeper D . The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol. 2005; 7(11):1074-82. DOI: 10.1038/ncb1314. View

2.
Ma L, Teruya-Feldstein J, Weinberg R . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449(7163):682-8. DOI: 10.1038/nature06174. View

3.
Li R, Liang J, Ni S, Zhou T, Qing X, Li H . A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell. 2010; 7(1):51-63. DOI: 10.1016/j.stem.2010.04.014. View

4.
MILLER I, Bieker J . A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins. Mol Cell Biol. 1993; 13(5):2776-86. PMC: 359658. DOI: 10.1128/mcb.13.5.2776-2786.1993. View

5.
Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M . DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005; 24(14):2375-85. DOI: 10.1038/sj.onc.1208429. View